Overview
This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.
Eligibility
Inclusion Criteria:
- Diagnosis of Type 3 TZ confirmed on exam prior to randomization
- Age 25 years or older
Exclusion Criteria:
- With Type 1 or 2 TZ prior to randomization
- Currently pregnant
- History of hysterectomy
- Any cancerous lesions
- Active cervicitis